# Global Registry for COL6-related Dystrophies

> **NCT04020159** · — · UNKNOWN · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 1000 (estimated)

## Conditions studied

- Bethlem Myopathy
- Ullrich Congenital Muscular Dystrophy 1, Digenic, Col6A1/Col6A2
- Ullrich Congenital Muscular Dystrophy 1, Autosomal Recessive
- Ullrich Congenital Muscular Dystrophy 1, Autosomal Dominant
- Bethlem Myopathy 1, Autosomal Recessive
- UCMD
- BTHLM1

## Interventions

- **OTHER:** Patient Registry

## Key facts

- **NCT ID:** NCT04020159
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2024-10
- **Final completion:** 2024-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2023-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04020159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04020159, "Global Registry for COL6-related Dystrophies". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04020159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
